P. Wade

发表

Antimicrobial Stewardship from Policy to Practice: Experiences from UK Antimicrobial Pharmacists

M. Gilchrist, H. Wickens, D. Ashiru-Oredope, 2015, Infectious Diseases and Therapy.

A pre–postintervention study to evaluate the impact of dose calculators on the accuracy of gentamicin and vancomycin initial doses

C. Whittlesea, G. Cavell, A. Hamad, 2015, BMJ Open.

Intervention planning for Antibiotic Review Kit (ARK): a digital and behavioural intervention to safely review and reduce antibiotic prescriptions in acute and general medicine

T. Peto, G. Barlow, R. Bellamy, 2019, The Journal of antimicrobial chemotherapy.

Impact of guidelines and enhanced antibiotic stewardship on reducing broad-spectrum antibiotic usage and its effect on incidence of Clostridium difficile infection.

B. Cooper, P. Wade, G. Gopal Rao, 2011, The Journal of antimicrobial chemotherapy.

Risk of medication safety incidents with antibiotic use measured by defined daily doses

C. Whittlesea, G. Cavell, A. Hamad, 2013, International Journal of Clinical Pharmacy.

Systemic antibiotics fail to clear multidrug-resistant Klebsiella from a pediatric ICU.

C. Roberts, H. V. van Saene, P. Wade, 2001, Chest.

Guidelines for prevention and control of group A streptococcal infection in acute healthcare and maternity settings in the UK.

M. Morgan, R. Cordery, J. Steer, 2012, The Journal of infection.

Antibiotic stewardship and early discharge from hospital: impact of a structured approach to antimicrobial management.

C. Winnard, W. Lawson, J. Coia, 2012, The Journal of antimicrobial chemotherapy.

A multisite evaluation of antifungal use in critical care: implications for antifungal stewardship

A. Fife, T. Planche, J. Edgeworth, 2022, JAC-antimicrobial resistance.

Successful treatment of Pseudomonas aeruginosa infective endocarditis via haemodialysis outpatient parenteral antimicrobial therapy: case report.

J. Klein, P. Wade, A. Arnold, 2019, The Journal of antimicrobial chemotherapy.

Understanding antibiotic resistance

H. Wickens, P. Wade, 2005 .

Performance evaluation of the Verigene® (Nanosphere) and FilmArray® (BioFire®) molecular assays for identification of causative organisms in bacterial bloodstream infections

P. Wade, S. Goldenberg, K. Stocker, 2015, European Journal of Clinical Microbiology & Infectious Diseases.

Performance evaluation of the Verigene® (Nanosphere) and FilmArray® (BioFire®) molecular assays for identification of causative organisms in bacterial bloodstream infections

P. Wade, S. Goldenberg, K. Stocker, 2015, European Journal of Clinical Microbiology & Infectious Diseases.

Subcutaneous ivermectin use in the treatment of severe Strongyloides stercoralis infection: two case reports and a discussion of the literature.

W. Newsholme, P. Wade, H. Soulsby, 2016, The Journal of antimicrobial chemotherapy.

Clinical features and management of individuals admitted to hospital with monkeypox and associated complications across the UK: a retrospective cohort study.

Mayur R Gamit, J. Canny, M. Beadsworth, 2022, The Lancet. Infectious diseases.

Mandatory reporting and improvements in diagnosing Clostridium difficile infection: an incompatible dichotomy?

G. French, D. Tucker, P. Wade, 2011, The Journal of infection.

The impact of the introduction of fidaxomicin on the management of Clostridium difficile infection in seven NHS secondary care hospitals in England: a series of local service evaluations

D. Jenkins, J. Sandoe, D. Nayar, 2015, European Journal of Clinical Microbiology & Infectious Diseases.

Effectiveness of early use of fidaxomicin in preventing recurrence of Clostridium difficile infection.

N. Wigglesworth, P. Wade, S. Goldenberg, 2019, The Journal of hospital infection.

Antimicrobial stewardship: an evidence-based, antimicrobial self-assessment toolkit (ASAT) for acute hospitals.

J. Cooke, E. Charani, W. Lawson, 2010, The Journal of antimicrobial chemotherapy.

Reduction in Clostridium difficile environmental contamination by hospitalized patients treated with fidaxomicin.

J. Otter, J. Biswas, E. van Kleef, 2015, The Journal of hospital infection.

The diagnosis of C. difficile infection (CDI) – Two steps forwards?

G. French, D. Tucker, P. Wade, 2011 .

Identifying best practices across three countries: hospital antimicrobial stewardship in the United Kingdom, France, and the United States.

Kavita K. Trivedi, M. Gilchrist, C. Dumartin, 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Kinetics and Toxicity of Liposomal and Conventional Amikacin in a Patient with Multidrug-Resistant Tuberculosis

I. Cropley, R. Davidson, T. Whitehead, 1998, European Journal of Clinical Microbiology and Infectious Diseases.

The impact of the introduction of fidaxomicin on the management of Clostridium difficile infection in seven NHS secondary care hospitals in England: a series of local service evaluations

D. Jenkins, D. Nayar, T. Planche, 2015, European Journal of Clinical Microbiology & Infectious Diseases.

Impact of guidelines and enhanced antibiotic stewardship on reducing broad-spectrum antibiotic usage and its effect on incidence of Clostridium difficile infection.

B. Cooper, P. Wade, G. Gopal Rao, 2011, The Journal of antimicrobial chemotherapy.